14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:RXDX
Delisted

Prometheus Biosciences Inc Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$199.92
+0 (+0%)
At Close: Sep 14, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $199.92 $199.92 Thursday, 14th Sep 2023 RXDX stock ended at $199.92. During the day the stock fluctuated 0% from a day low at $199.92 to a day high of $199.92.
90 days $199.92 $199.92
52 weeks $30.75 $199.96

Historical Prometheus Biosciences Inc prices

Date Open High Low Close Volume
Jul 05, 2023 $199.92 $199.92 $199.92 $199.92 0
Jul 03, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 30, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 29, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 28, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 27, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 26, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 23, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 22, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 21, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 20, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 16, 2023 $199.92 $199.92 $199.92 $199.92 0
Jun 15, 2023 $199.68 $199.96 $199.92 $199.92 1 787 021
Jun 14, 2023 $199.02 $199.74 $199.02 $199.74 920 695
Jun 13, 2023 $198.99 $199.02 $198.92 $198.99 3 509 752
Jun 12, 2023 $198.99 $199.00 $198.92 $198.92 1 339 693
Jun 09, 2023 $199.00 $199.07 $198.92 $198.99 938 014
Jun 08, 2023 $199.20 $199.20 $198.85 $198.98 295 854
Jun 07, 2023 $199.08 $199.08 $198.78 $198.84 407 221
Jun 06, 2023 $198.80 $199.08 $198.73 $198.85 394 376
Jun 05, 2023 $198.75 $198.85 $198.71 $198.80 336 461
Jun 02, 2023 $198.75 $198.87 $198.60 $198.83 366 133
Jun 01, 2023 $198.60 $198.77 $198.56 $198.65 534 400
May 31, 2023 $198.50 $198.78 $198.38 $198.70 937 864
May 30, 2023 $198.60 $198.63 $198.40 $198.58 1 207 461
Click to get the best stock tips daily for free!

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT